HSF1 and cancer: Santagata et al. first reported inhibition of glucose flux in cancer cells upon translation inhibition induced by treatment with rocaglates, which was mediated by inactivation of HSF1 and subsequent upregulation of TXNIP, one of the main negative regulators of glucose uptake.20